Literature DB >> 30804512

Neurofilament makes light of MS treatment monitoring.

Ian Fyfe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30804512     DOI： 10.1038/s41582-019-0156-6

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  2 in total

1.  Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients.

Authors:  Gloria Dalla Costa; Vittorio Martinelli; Lucia Moiola; Francesca Sangalli; Bruno Colombo; Annamaria Finardi; Paola Cinque; Eva-Maria Kolb; Aiden Haghikia; Ralf Gold; Roberto Furlan; Giancarlo Comi
Journal:  Ann Neurol       Date:  2019-03-05       Impact factor: 10.422

2.  Blood neurofilament light chain as a biomarker of MS disease activity and treatment response.

Authors:  Jens Kuhle; Harald Kropshofer; Dieter A Haering; Uma Kundu; Rolf Meinert; Christian Barro; Frank Dahlke; Davorka Tomic; David Leppert; Ludwig Kappos
Journal:  Neurology       Date:  2019-02-08       Impact factor: 9.910
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.